Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.


Biological Chemistry

‘Junk DNA’ Not So Junky

Encode consortium finds function in most of the genome, not just in a small part as originally believed

by Stu Borman
September 10, 2012 | APPEARED IN VOLUME 90, ISSUE 37

Credit: National Institutes of Health
In this artistic rendering, proteins interact with genomic DNA unwinding out of a chromosome.
Credit: National Institutes of Health
In this artistic rendering, proteins interact with genomic DNA unwinding out of a chromosome.

The first sequencing of the human genome about a decade ago showed that 2% of DNA coded for proteins and the rest seemed to represent “junk DNA” of unknown function. Studies by the worldwide Encode (Encyclopedia of DNA Elements) consortium now reveal that at least 80% of the genome contains areas that interact with regulatory proteins, switch processes on and off, can be transcribed into gene-regulating RNAs, or perform other functions. The findings, published in 30 open-access papers in Nature,Science,Genome Research,Genome Biology, and other journals, represent an advance in understanding how the genome works. For example, the data “help explain how genetic variants that do not affect the structure of encoded proteins could affect a person’s susceptibility to disease,” says Encode member Ross C. Hardison of Pennsylvania State University. Genomewide association studies had found disease susceptibility in noncoding regions of the genome, suggesting they were functionally significant. Encode data now fully support that contention. “These papers represent a tectonic shift in our understanding of the intricate circuitry that makes the human genome work,” says Encode member Thomas D. Tullius of Boston University. “To me, the most exciting new insight is the central role that gene regulatory regions play in disease, opening the way for entirely new strategies for therapeutic intervention.” Future Encode studies will provide additional details on genomic functions. But the current work already reveals that “there is very little, if any, junk DNA,” says Eric D. Green, director of the National Human Genome Research Institute, which helps fund Encode.



This article has been sent to the following recipient:

Leave A Comment

*Required to comment